Peter Paschka

Peter Paschka

UNVERIFIED PROFILE

Are you Peter Paschka?   Register this Author

Register author
Peter Paschka

Peter Paschka

Publications by authors named "Peter Paschka"

Are you Peter Paschka?   Register this Author

70Publications

2672Reads

50Profile Views

Genomic Classification and Prognosis in Acute Myeloid Leukemia.

N Engl J Med 2016 Jun;374(23):2209-2221

Cancer Genome Project, Wellcome Trust Sanger Institute (E.P., M.G., N.D.R., N.B., G.G., P.V.L., I.M., L.M., S.M., S.O., K.R., D.R.J., J.W.T., A.P.B., P.J.C.), and the European Bioinformatics Institute, European Molecular Biology Laboratory (EMBL-EBI) (M.G.), Hinxton, the Centre for Evolution and Cancer, Institute of Cancer Research, London (N.E.P., M.F.G.), and the Department of Haematology, University of Cambridge, Cambridge (N.B.) - all in the United Kingdom; the Departments of Epidemiology and Biostatistics and Cancer Biology, the Center for Molecular Oncology and the Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York (E.P.); the Department of Internal Medicine III, Ulm University, Ulm (L.B., V.I.G., P.P., K.D., R.F.S., H.D.), and the Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover (M.H., F.T., A.G.) - both in Germany; the Division of Hematology, Fondazione IRCCS, Istituto Nazionale dei Tumori, and Department of Oncology and Onco-Hematology, University of Milan, Milan (N.B.); the Department of Human Genetics, University of Leuven, Leuven, Belgium (P.V.L.); and the Department of Pathology, University of Otago, Christchurch, New Zealand (P.G., P.J.C.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1516192DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979995PMC
June 2016

Core-binding factor acute myeloid leukemia: can we improve on HiDAC consolidation?

Hematology Am Soc Hematol Educ Program 2013 ;2013:209-19

1Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2013.1.209DOI Listing
December 2014

Intermediate-risk acute myeloid leukemia therapy: current and future.

Hematology Am Soc Hematol Educ Program 2014 Dec 18;2014(1):34-43. Epub 2014 Nov 18.

Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2014.1.34DOI Listing
December 2014

The clinical relevance of Wilms Tumour 1 (WT1) gene mutations in acute leukaemia.

Hematol Oncol 2010 Mar;28(1):13-9

Division of Hematology and Hematological Malignancies, University of Calgary, 601A South Tower, Foothills Medical Centre, 1403-29th Street NW, Calgary, Alberta, T2N 2T9, Canada.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/hon.931
Publisher Site
http://dx.doi.org/10.1002/hon.931DOI Listing
March 2010

Advances in molecular genetics and treatment of core-binding factor acute myeloid leukemia.

Curr Opin Oncol 2008 Nov;20(6):711-8

Division of Hematology and Oncology, Department of Internal Medicine, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210-1228, USA.

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=00001622-200811000-000
Publisher Site
http://dx.doi.org/10.1097/CCO.0b013e32831369dfDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3677535PMC
November 2008

Core binding factor acute myeloid leukemia.

Authors:
Peter Paschka

Semin Oncol 2008 Aug;35(4):410-7

Medizinische Klinik II, Klinikum der JW Goethe Universität, Frankfurt am Main, Germany.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S009377540800121
Publisher Site
http://dx.doi.org/10.1053/j.seminoncol.2008.04.011DOI Listing
August 2008

Dynamics of BCR-ABL mutated clones prior to hematologic or cytogenetic resistance to imatinib.

Haematologica 2008 Feb 26;93(2):186-92. Epub 2008 Jan 26.

III. Medizinische Klinik, Medizinische, Fakultät Mannheim der Universität Heidelberg, Mannheim, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.11993DOI Listing
February 2008

Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification?

Blood 2007 Jan 7;109(2):431-48. Epub 2006 Sep 7.

Department of Internal Medicine, The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Room 1248B, The Ohio State University, 300 West Tenth Ave, Columbus, OH 43210-1228, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2006-06-001149DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1785102PMC
January 2007

Independent confirmation of a prognostic gene-expression signature in adult acute myeloid leukemia with a normal karyotype: a Cancer and Leukemia Group B study.

Blood 2006 Sep 2;108(5):1677-83. Epub 2006 May 2.

Division of Hematology and Oncology, Department of Internal Medicine, Comprehensive Cancer Center, The Ohio State University, Suite A455 Starling-Loving Hall, 320 West Tenth Ave, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2006-02-005538DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1895508PMC
September 2006

Standardization of preanalytical factors for minimal residual disease analysis in chronic myelogenous leukemia.

Acta Haematol 2004 ;112(1-2):30-3

III. Medizinische Universitätsklinik Mannheim der Universität Heidelberg, Mannheim, Deutschland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000077557DOI Listing
July 2004

Molecular surveillance of chronic myeloid leukemia patients in the imatinib era - evaluation of response and resistance.

Acta Haematol 2004 ;112(1-2):85-92

III. Medizinische Klinik, Fakultät für Klinische Medizin Mannheim der Universität Heidelberg, Mannheim, Germany.

View Article

Download full-text PDF

Source
https://www.karger.com/Article/FullText/77563
Publisher Site
http://dx.doi.org/10.1159/000077563DOI Listing
July 2004